MDGL
Madrigal Pharmaceuticals, Inc.Company with tickers: MDGL
CIK
1157601
CUSIP
558868105
Shares Outstanding
23,055,659
13F Activity (30d)
324 filings
324 filers
Price
$524.28
Market Cap
$12.09B
P/E Ratio
-26.23
EPS (Diluted)
$-19.99
52W High
$615.00
52W Low
$265.00
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $137,250,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $216,561,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Research & Development | — | ||||
| Operating Income | $-79,311,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-73,238,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-17.33 | USD/shares | 2023-12-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-17.33 | USD/shares | 2023-12-31 | 10-Q | 2026-05-06 |